Jordan-based Hikma Pharmaceuticals is planning to buy 30% stake in Mumbai-based API maufacturing firm Unimark Remedies Limited according to DealCurry report. Unimark has two active pharmaceutical ingredient (API) plants at Vapi and Bavla, in Gujarat, both USFDA approved, and a third one in Khopoli, Maharashtra. The total investment on the units is approximately $66 million (Rs 298 crore).
Read full report on this link